<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159922">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107794</url>
  </required_header>
  <id_info>
    <org_study_id>12-007708</org_study_id>
    <nct_id>NCT02107794</nct_id>
  </id_info>
  <brief_title>Shared Decision Making in Graves Disease - Graves Disease (GD) Choice</brief_title>
  <official_title>Shared Decision Making in Graves Disease - Graves Disease (GD) Choice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators' decision aid for patients with GD, GD Choice, will be the result of a
      user-centered participatory action research involving) synthesis of the best available
      evidence from the literature and real-world registry experience, ii) input and involvement
      of patients, clinicians and other stakeholders, iii) direct observation of encounters and
      iv) extensive field-testing. The goal is to create a decision aid that will be rigorously
      evidence-based, clear and complete, able to be used by clinicians with minimal training
      time, while satisfying extant standards for rigorous high-quality shared decision making
      tools.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Decisional Quality (Knowledge, Decisional Conflict, Satisfaction) of 100 participants</measure>
    <time_frame>up to 2 weeks post-visit</time_frame>
    <safety_issue>No</safety_issue>
    <description>Outcome measure to be assessed through post-visit surveys.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">147</enrollment>
  <condition>Graves' Disease</condition>
  <condition>Thyroid Disease</condition>
  <condition>Hyperthyroidism</condition>
  <arm_group>
    <arm_group_label>Decision Aid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Observation of clinical encounter using the decision aid, via video, audio or written notes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Observations in clinical encounters, either video, audio, or observational notes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Decision Aid</intervention_name>
    <description>Paper based decision aid will be utilized to facilitate treatment option conversation between clinician and patient.</description>
    <arm_group_label>Decision Aid</arm_group_label>
    <other_name>DA</other_name>
    <other_name>Decision Aid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults â‰¥ 18 years

          -  Diagnosis of Graves Disease

          -  Appointment with endocrinologist to discuss treatment options for Graves Disease

        Exclusion Criteria:

          -  Major barriers to participate in shared decision making or to providing informed
             consent (i.e. dementia, severe hearing or visual impairment)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor M Montori, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan P Brito Campana, MBBS</last_name>
    <phone>507-284-2617</phone>
    <email>brito.juan@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sara Dick</last_name>
    <phone>507-538-3254</phone>
    <email>dick.sara@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan P Brito Campana, MBBS</last_name>
      <phone>507-284-4080</phone>
      <email>Brito.Juan@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sara Dick</last_name>
      <phone>507-538-3254</phone>
      <email>dick.sara@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Juan P Brito Campana, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victor M Montori, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 4, 2014</lastchanged_date>
  <firstreceived_date>March 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Victor Montori</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Grave's</keyword>
  <keyword>Disease</keyword>
  <keyword>Thyroid</keyword>
  <keyword>Hyperthyroidism</keyword>
  <keyword>Thyroidectomy</keyword>
  <keyword>Radioactive</keyword>
  <keyword>Iodine</keyword>
  <keyword>Antithyroid</keyword>
  <keyword>Shared</keyword>
  <keyword>Decision</keyword>
  <keyword>Making</keyword>
  <keyword>Aid</keyword>
  <keyword>Evidence</keyword>
  <keyword>Based</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Mayo</keyword>
  <keyword>Clinic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Graves Disease</mesh_term>
    <mesh_term>Hyperthyroidism</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
